Targeted delivery of therapeutic oligonucleotides in pancreatic cancer
Journal of Biology and Medicine · 2022
DOI: 10.17352/jbm.000028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biology and Medicine, 2022. Verfasst von Yang Iris. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Currently, the most common treatment options for pancreatic cancer include chemotherapy, radiation, and surgery. These treatment options are not specific to the cause of the disease and therefore result in a large number of side effects including nausea, fatigue, hair loss, etc. The use of oligonucleotides may be a more efficient and safe method of cancer therapy. This mini-review will cover how oligonucleotides have been used to treat diseases in the past as well as different methods for delivery into the body and finally the applications of oligonucleotides in pancreatic cancer therapy.
Zitieren
APA
Iris, Y. (2022). Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine. https://doi.org/10.17352/jbm.000028
Vancouver
Iris Y. Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine. 2022. doi:10.17352/jbm.000028
BibTeX
@article{Iris2022,
author = {Iris, Yang},
title = {Targeted delivery of therapeutic oligonucleotides in pancreatic cancer},
journal = {Journal of Biology and Medicine},
year = {2022},
doi = {10.17352/jbm.000028}
}
EUVIMED